Cardiac Arrest Clinical Trials

Find Cardiac Arrest Clinical Trials Near You

Comparison of Scores for Early Brain Damage Assessment at Intensive Care Unit Admission After Cardiac Arrest

Status: Recruiting
Location: See all (5) locations...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

Even in patients with successful return of spontaneous circulation (ROSC), outcome after cardiac arrest remains poor. The overall in-hospital survival rate widely varies both worldwide and across communities, from 1 to 4 folds according to circumstances of arrest and post-resuscitation interventions. Several studies have already shown that early interventions performed after ROSC, such as treatment of the cause, targeted temperature management, optimal hemodynamic management and extra-corporeal life support in selected patients, could improve the outcome in post-cardiac arrest patients. However, the decision process regarding the allocation of these resources, in parallel with the management of patients' proxies, remains a complex challenge for physicians facing these situations. Consequently, several prediction models and scores have been developed in order to stratify the risk of unfavorable outcome and to discriminate the best candidates for post-resuscitation interventions. Overall, several scores exist, but external validation are lacking and direct comparisons are needed to assess relative interest of scoring systems. Indeed, establishing the optimal scoring system is crucial, for optimal treatment allocation and appropriate information to relatives.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• all adult patients, major, admitted to intensive care after cardiac arrest (after both in and out-of hospital cardiac arrest),

• comatose (defined by Glasgow score ≤ 8) on admission,

Locations
Other Locations
France
Hopital Jacques Cartier
RECRUITING
Massy
CHU Nantes
RECRUITING
Nantes
Clinique Ambroise Paré
RECRUITING
Neuilly-sur-seine
APHP, Cochin
RECRUITING
Paris
CH Versailles
RECRUITING
Versailles
Contact Information
Primary
Jean Baptiste Lascarrou, MD, PhD
jeanbaptiste.lascarrou@chu-nantes.fr
+33240087376
Backup
Alain Cariou, MD, PhD
alain.cariou@aphp.fr
Time Frame
Start Date: 2022-11-02
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 4500
Related Therapeutic Areas
Sponsors
Leads: AfterROSC

This content was sourced from clinicaltrials.gov